Dark

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ

At Close

May 8, 2025 3:59:30 PM EDT

1.05USD+3.164%(+0.03)69,105

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 7, 2025 9:08:30 AM EDT

1.02USD+0.226%(+0.00)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

25.19M

Industry

Biotechnology

NRSN Stats

Avg. Vol. 10 Day

101,477

Avg. Vol. 30 Day

120,257

Employees

Market Cap

25,185,704

Shares Out.

23,988,669

On/Off Exchange

33%/67%

6 Month Beta

0.07

1 Year Beta

0.34

2 Year Beta

0.49

3 Year Beta

0.25

52 Week Low

0.51

52 Week High

1.50

SMA50

1.04

SMA200

1.06

1 Week

+1.17%

1 Month

+10.77%

3 Month

-9.49%

6 Month

-18.61%

1 Year

-14.64%

2 Year

-39.31%

5 Year

-74.01%

Profile

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa

NRSN Stock Summary

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $1.05, and today's volume is 69,105. NRSN is up 3.164% today. The 30 day average volume is 120,257. NRSN market cap is 25.19M with 23,988,669 shares outstanding.

.dark-mode .clRtl0{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .clRtl0{ color: #333333; background-color: white; border: 2px solid #333333; }NRSNNeuroSense Therapeutics Ltd.stock NASDAQ

NRSN Stock Summary

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ